• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125350-15
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/07/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Medical devices: dilatation catheter: chocolate (medtronic), guiding catheter: guideliner.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined that the reported device damaged by another device appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.(b)(4).
 
Event or Problem Description
It was reported the procedure was performed to treat a heavily calcified tight lesion in the left anterior descending (lad) coronary artery.Several balloons were used to complete pre-dilatation because the lesion was very tight.The 3.5 x 15 mm xience alpine stent delivery system (sds) was advanced to the tightest part of the lesion and deployed successfully.The stent was fully apposed; however, further ballooning was required because the lesion was still tight just distal to the implanted stent due to the high calcium in the lesion.During removal of the balloon catheter and guideliner catheter, the implanted stent was explanted.The explanted stent was on the balloon catheter and all devices were removed together from the patients anatomy.Several balloon catheters were used in an attempt to cross the lesion a second time, but nothing crossed; therefore, the procedure was aborted.There was no adverse patient effect and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key7520767
Report Number2024168-2018-03665
Device Sequence Number11122361
Product Code NIQ
UDI-Device Identifier08717648199523
UDI-Public08717648199523
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date (Section B) 05/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/18/2021
Device Catalogue Number1125350-15
Device Lot Number8013161
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/10/2018
Initial Report FDA Received Date05/16/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age67 YR
-
-